Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1955 3
1958 1
1959 3
1960 4
1961 1
1962 1
1963 1
1966 1
1970 1
1971 1
1972 1
1976 1
1978 2
1983 1
1988 1
1990 1
1997 1
1998 2
2000 1
2001 1
2002 2
2003 1
2004 3
2005 1
2006 2
2007 4
2008 5
2009 3
2010 3
2011 10
2012 6
2013 8
2014 6
2015 3
2016 4
2017 8
2018 10
2019 8
2020 9
2021 5
2022 3
2023 5
2024 4
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Connors JM, Jurczak W, Straus DJ, Ansell SM, Kim WS, Gallamini A, Younes A, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Oki Y, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Chen R, Ramchandren R, Zinzani PL, Cunningham D, Rosta A, Josephson NC, Song E, Sachs J, Liu R, Jolin HA, Huebner D, Radford J; ECHELON-1 Study Group. Connors JM, et al. N Engl J Med. 2018 Jan 25;378(4):331-344. doi: 10.1056/NEJMoa1708984. Epub 2017 Dec 10. N Engl J Med. 2018. PMID: 29224502 Free PMC article. Clinical Trial.
[Agamma-globulinemia].
KRATKOVA E, MARKOVA J, PECHAR J. KRATKOVA E, et al. Among authors: markova j. Cas Lek Cesk. 1962 Feb 23;101:238-42. Cas Lek Cesk. 1962. PMID: 14459386 Czech. No abstract available.
DNMT3A mutations in AML: a new prognostic factor?
Schwarz J, Marková J. Schwarz J, et al. Among authors: markova j. Leuk Res. 2013 Nov;37(11):1432-3. doi: 10.1016/j.leukres.2013.08.012. Epub 2013 Sep 6. Leuk Res. 2013. PMID: 24045027 No abstract available.
A novel germline hyperactivating JAK2 mutation L604F.
Dvořáček L, Marková J, Holoubek A, Grebeňová D, Kundrát D, Kuželová K, Schwarz J. Dvořáček L, et al. Among authors: markova j. Ann Hematol. 2023 Oct;102(10):2725-2734. doi: 10.1007/s00277-023-05423-y. Epub 2023 Aug 28. Ann Hematol. 2023. PMID: 37639050 Free PMC article.
Outcome of elderly patients with classical Hodgkin's lymphoma.
Sykorova A, Mocikova H, Lukasova M, Koren J, Stepankova P, Prochazka V, Belada D, Klaskova K, Gaherova L, Chroust K, Buresova L, Markova J; Czech Hodgkin’s Lymphoma Study Group. Sykorova A, et al. Among authors: markova j. Leuk Res. 2020 Mar;90:106311. doi: 10.1016/j.leukres.2020.106311. Epub 2020 Jan 24. Leuk Res. 2020. PMID: 32050133
Nature of frequent deletions in CEBPA.
Fuchs O, Kostecka A, Provaznikova D, Krasna B, Brezinova J, Filkukova J, Kotlin R, Kouba M, Kobylka P, Neuwirtova R, Jonasova A, Caniga M, Schwarz J, Markova J, Maaloufova J, Sponerova D, Novakova L, Cermak J. Fuchs O, et al. Among authors: markova j. Blood Cells Mol Dis. 2009 Nov-Dec;43(3):260-3. doi: 10.1016/j.bcmd.2009.07.001. Epub 2009 Aug 3. Blood Cells Mol Dis. 2009. PMID: 19651529
129 results